
Mezocar LA 300mg Tablet
Marketer
Pulse Pharmaceuticals
Salt Composition
Carbamazepine (300mg)
Overview Mezocar LA 300mg Tablet
Carbamazepine extended-release 300mg tablets are prescribed to manage epilepsy, preventing seizures. This medication also treats trigeminal neuralgia (facial nerve pain) and diabetic neuropathy. Dosage is determined by your physician; take it consistently, at the same time daily, with or without food. Gradual dosage increases may be necessary. Inform your doctor of all other medications you're using to avoid interactions. Regular, consistent use is crucial for maximum effectiveness, even when feeling well; missed doses or abrupt cessation can worsen your condition or trigger seizures. Common side effects include nausea, vomiting, dizziness, drowsiness, imbalance, constipation, dry mouth, and itching. Vision changes and slurred speech may occur. Report skin rashes, depression, or suicidal thoughts immediately. Prior to commencing treatment, disclose any pre-existing heart conditions, kidney or liver diseases, urinary issues, or mental health concerns, as these factors influence treatment. Blood tests (e.g., CBC) might be recommended before and during treatment to monitor your progress.
Primary Ingredients of Mezocar LA 300mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Mezocar LA 300mg Tablet
Nerve damage in diabetes | Trigeminal neuralgia | Epileptic seizures
Major Benefits of Mezocar LA 300mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mezocar LA 300mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mezocar LA 300mg Tablet:
- Dizziness
- Nausea
- Vomiting
- Constipation
- Sleepiness
- Abnormality of voluntary movements
How to use Mezocar LA 300mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mezocar LA 300mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Mezocar LA 300mg Tablet works:
Carbamazepine Extended-Release 300mg tablets are used to manage epilepsy. This medication works by reducing the overactive electrical signaling in the brain that causes seizures.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Mezocar LA 300mg tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Mezocar LA 300mg tablets is contraindicated during pregnancy due to confirmed fetal risk. Exceptions may be made in life-threatening circumstances where the potential benefits outweigh the known hazards, at the sole discretion of a physician. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Mezocar LA 300mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Mezocar LA 300mg Tablet might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mezocar LA 300mg tablets to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Mezocar LA 300mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mezocar LA 300mg Tablet :
Should you forget a Mezocar LA 300mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mezocar LA 300mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Stilbene Imine Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
